99409-32-2 Usage
Description
Ethyl 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-b-D-thioglucopyranoside is a complex organic compound that serves as a key intermediate in the synthesis of various biologically active molecules. It is characterized by its unique structure, which includes an ethyl group, three acetyl groups, a deoxy sugar moiety, and a phthalimido group. Ethyl 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-b-D-thioglucopyranoside plays a crucial role in the development of pharmaceuticals and other applications.
Uses
Used in Pharmaceutical Industry:
Ethyl 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-b-D-thioglucopyranoside is used as a reactant in the synthesis of Me 2-amino-2-deoxy-a-D-glucopyranoside 6-phosphate and Me 2-amino-2-deoxy-b-D-glucopyranoside 6-phosphate. These synthesized compounds act as cell wall inhibitors targeting the GlmM and GlmU enzymes in Mycobacterium tuberculosis, which are responsible for the biosynthesis of a key component of bacterial cell walls. By inhibiting these enzymes, the compound can potentially contribute to the development of new treatments for tuberculosis.
Check Digit Verification of cas no
The CAS Registry Mumber 99409-32-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,9,4,0 and 9 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 99409-32:
(7*9)+(6*9)+(5*4)+(4*0)+(3*9)+(2*3)+(1*2)=172
172 % 10 = 2
So 99409-32-2 is a valid CAS Registry Number.
99409-32-2Relevant articles and documents
ANTIMICROBIAL VACCINE COMPOSITIONS
-
Paragraph 0081-0084, (2021/03/05)
This invention is directed to antimicrobial vaccine compounds and compositions comprising oligosaccharide β-(1→6)- glucosamine groups having from 3 to 12 glucosamine units linked through a linker group to tetanus toxoid wherein the toxoid is primarily in
METHODS FOR PROVIDING CONTINUOUS THERAPY AGAINST PNAG COMPRISING MICROBES
-
Paragraph 0078-0081, (2021/05/29)
Disclosed are antimicrobial vaccines comprising oligosaccharide β-(1→6)-glucosamine groups.
Triflic acid-mediated synthesis of thioglycosides
Escopy, Samira,Singh, Yashapal,Demchenko, Alexei V.
supporting information, p. 8379 - 8383 (2019/09/30)
An efficient synthesis of thioglycosides from per-acetates in the presence of triflic acid is described. The developed protocol features high reaction rates and product yields. Some reactive sugar series give high efficiency in the presence of sub-stoichiometric trifluoromethanesulfonic acid (TfOH) in contrast to other known protocols that require multiple equivalents of Lewis acids to reach high conversion rates.
